Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC

Convalescent plasma with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) antibodies (CCP) may hold promise as a treatment for coronavirus disease 2019 (COVID-19). We compared the mortality and clinical outcome of patients with COVID-19 who received 200 mL of CCP with a spike protein IgG...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Hyun ah, Bartash, Rachel, Gendlina, Inessa, Rivera, Johanna, Nakouzi, Antonio, Bortz, Robert H., Wirchnianski, Ariel S., Paroder, Monika, Fehn, Karen, Serrano-Rahman, Leana, Babb, Rachelle, Sarwar, Uzma N., Haslwanter, Denise, Laudermilch, Ethan, Florez, Catalina, Dieterle, M. Eugenia, Jangra, Rohit K., Fels, J. Maximilian, Tong, Karen, Mariano, Margarette C., Vergnolle, Olivia, Georgiev, George I., Herrera, Natalia G., Malonis, Ryan J., Quiroz, Jose A., Morano, Nicholas C., Krause, Gregory J., Sweeney, Joseph M., Cowman, Kelsie, Allen, Stephanie, Annam, Jayabhargav, Applebaum, Ariella, Barboto, Daniel, Khokhar, Ahmed, Lally, Brianna J., Lee, Audrey, Lee, Max, Malaviya, Avinash, Sample, Reise, Yang, Xiuyi A., Li, Yang, Ruiz, Rafael, Thota, Raja, Barnhill, Jason, Goldstein, Doctor Y., Uehlinger, Joan, Garforth, Scott J., Almo, Steven C., Lai, Jonathan R., Gil, Morayma Reyes, Fox, Amy S., Chandran, Kartik, Wang, Tao, Daily, Johanna P., Pirofski, Liise-anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934933/
https://www.ncbi.nlm.nih.gov/pubmed/33476300
http://dx.doi.org/10.1172/jci.insight.142270

Ejemplares similares

Ejemplares similares